Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margarida Alves

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Helicobacter|September 1, 2007
Brazilian green propolis on Helicobacter pylori infection. a pilot clinical studyLuiz Gonzaga Vaz Coelho, Esther Margarida Alves Ferreira Bastos, Clarissa Carvalho Resende, et al.
Annals of the Rheumatic Diseases|September 29, 2020
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR databaseAnna-Maria Hoffmann-Vold, Yannick Allanore, Margarida Alves, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Wiener Klinische Wochenschrift|August 11, 2021
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trialPeter G Kremsner, Philipp Mann, Arne Kroidl, et al.
Human Vaccines & Immunotherapeutics|October 18, 2024
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation studyBrandon J Essink, Craig Shapiro, Marie Grace Dawn Isidro, et al.
Arthritis Research & Therapy|July 10, 2026
Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohortTim Filla, Alexandru Micu, Lasse Hansen, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Helicobacter|September 1, 2007
Brazilian green propolis on Helicobacter pylori infection. a pilot clinical studyLuiz Gonzaga Vaz Coelho, Esther Margarida Alves Ferreira Bastos, Clarissa Carvalho Resende, et al.
Annals of the Rheumatic Diseases|September 29, 2020
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR databaseAnna-Maria Hoffmann-Vold, Yannick Allanore, Margarida Alves, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Wiener Klinische Wochenschrift|August 11, 2021
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trialPeter G Kremsner, Philipp Mann, Arne Kroidl, et al.
Human Vaccines & Immunotherapeutics|October 18, 2024
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation studyBrandon J Essink, Craig Shapiro, Marie Grace Dawn Isidro, et al.
Arthritis Research & Therapy|July 10, 2026
Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohortTim Filla, Alexandru Micu, Lasse Hansen, et al.
Pageof 6